Lexaria Bioscience Corp (LEXX)

$6.41 0.00 (0.00%)

16:00 EDT LEXX Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 22, 2021

Good morning! It's time to start off another busy day of trading with a look at the biggest pre-market stock movers for Thursday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range 6.41 - 6.41

52-Week Range 3.98 - 12.50

Dividend & Yield N/A (N/A)

LEXX Stock Predictions, Articles, and Lexaria Bioscience Corp News

From the Web

Lexaria's R&D Program Reveals 5 Exciting Results Within 2 Months

From Benzinga Jul 29, 2021

Image by Lucas Vasques on Unsplash Biotech company Lexaria Bioscience Corp. (NASDAQ: LEXX) has been making news for DehydraTECH™ — its proprietary disruptive and cost-...

Lexaria's DehydraTECH-CBD Lowers Blood Pressure

From Lexaria Bioscience Corp. Jul 29, 2021

Human Clinical Study HYPER-H21-1 evidences a rapid and sustained drop in blood pressure with DehydraTECH-CBD and excellent tolerability KELOWNA, BC / ACCESSWIRE / July 29, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is extremely pleased to issue partial results from human clinical study HYPER-H21-1 evaluating DehydraTECHTM-processed cannabidiol ("CBD")

DehydraTECH-Enabled Consumer Products Now Available in Over 7,000 Stores

From Lexaria Bioscience Corp. Jul 28, 2021

Lexaria's technology empowers brands nationwide in stores including Albertsons, Hudson News, and many more KELOWNA, BC / ACCESSWIRE / July 28, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that its DehydraTECHTM technology has been embraced by consumer brands now available for sale in over 7,000 stores across the US. "Lexaria's

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

From Benzinga Jul 27, 2021

Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) shares increased by 131.41% to $7.22 during Tuesday's pre-market session. The company's market cap stands at $51.2...

Lexaria Completes Dosing in Human Clinical Study HYPER-H21-2

From Lexaria Bioscience Corp. Jul 27, 2021

Additionally, second patent award received in Japan KELOWNA, BC / ACCESSWIRE / July 27, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that dosing has been completed in its second human clinical study of 2021. Human clinical study HYPER-H21-2 consisted of 16 human volunteers who were pre- or mildly hypertensive and received three

Lexaria Receives US$3,817,643 From Warrant Exercises

From Lexaria Bioscience Corp. Jul 26, 2021

KELOWNA, BC / ACCESSWIRE / July 26, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the receipt of US$3,817,643 from the exercise of share purchase warrants (the "Warrants"). The Warrants were issued by the Company pursuant to its January 2021 public underwritten offering (the "Offering") whereby the shares and Warrants issued